AI Summary
Thinking
Thinking
We reviewed 3 live results for brca1 brca2 and narrowed them down to the 3 options that look most worth comparing first.
The options are BRCA1/BRCA2 A VISEE THERANOSTIQUE, 23andMe DNA Testing Kit for Health + Ancestry and Genetic (BRCA1&2) Screening Test.
Source: Cerba lab
Description
L'examen BRCA1/BRCA2 à visée théranostique proposé par le laboratoire Cerba est un panel génétique réalisé par séquençage à haut débit NGS. Destiné à l'oncogénétique pour des cancers tels que le sein, l'ovaire, la prostate, le pancréas et l'endomètre, il analyse l'ADN à partir de sang total EDTA. Le délai moyen de rendu est de 60 jours pour un tarif hors nomenclature de 882,9 euros, nécessitant une prescription médicale spécialisée.
Best for
Médecins spécialistes, Oncologues, Orientation théranostique en oncologie and Recherche de mutations BRCA1 et BRCA2
Rate this product
Source: 23andMe
Description
The 23andMe DNA Testing Kit for Health + Ancestry provides over 110 personalised genetic reports covering health predispositions, carrier status, wellness traits, and ancestry composition from saliva samples. The kit includes FDA-authorized genetic health risk reports for conditions such as BRCA1/BRCA2 variants and celiac disease, carrier screening for inherited conditions like cystic fibrosis, lifestyle wellness insights, and ancestry mapping across thousands of global regions, processed in CLIA-certified U.S. laboratories.
Best for
Individuals exploring hereditary health risks, Prospective parents wanting carrier status screening, Learning genetic predispositions to specific health conditions and Discovering ethnic lineage and geographic ancestry
Rate this product
Source: The Cancer Centre
Description
The Cancer Centre in Singapore provides Genetic (BRCA1 & BRCA2) Screening Tests to assess hereditary cancer risks, particularly for breast, ovarian, pancreatic, and prostate cancers. The screening helps identify inherited gene mutations that elevate cancer risk, enabling individuals with a family history or specific clinical indicators to pursue tailored medical management, enhanced surveillance like mammograms and MRIs, or preventive surgical interventions with specialist consultation.
Best for
Individuals with a family history of breast or ovarian cancer, Patients seeking proactive hereditary cancer risk assessment, Hereditary cancer risk screening and Preventive oncology planning
Rate this product
| Compare | #1BRCA1/BRCA2 A VISEE THERANOSTIQUE | #223andMe DNA Testing Kit for Health + Ancestry | #3Genetic (BRCA1&2) Screening Test |
|---|---|---|---|
| Source | Cerba lab | 23andMe | The Cancer Centre |
| Description | L'examen BRCA1/BRCA2 à visée théranostique proposé par le laboratoire Cerba est un panel génétique réalisé par séquençage à haut débit NGS. Destiné à l'oncogénétique pour des cancers tels que le sein, l'ovaire, la prostate, le pancréas et l'endomètre, il analyse l'ADN à partir de sang total EDTA. Le délai moyen de rendu est de 60 jours pour un tarif hors nomenclature de 882,9 euros, nécessitant une prescription médicale spécialisée. | The 23andMe DNA Testing Kit for Health + Ancestry provides over 110 personalised genetic reports covering health predispositions, carrier status, wellness traits, and ancestry composition from saliva samples. The kit includes FDA-authorized genetic health risk reports for conditions such as BRCA1/BRCA2 variants and celiac disease, carrier screening for inherited conditions like cystic fibrosis, lifestyle wellness insights, and ancestry mapping across thousands of global regions, processed in CLIA-certified U.S. laboratories. | The Cancer Centre in Singapore provides Genetic (BRCA1 & BRCA2) Screening Tests to assess hereditary cancer risks, particularly for breast, ovarian, pancreatic, and prostate cancers. The screening helps identify inherited gene mutations that elevate cancer risk, enabling individuals with a family history or specific clinical indicators to pursue tailored medical management, enhanced surveillance like mammograms and MRIs, or preventive surgical interventions with specialist consultation. |
| Best for | Médecins spécialistes, Oncologues, Orientation théranostique en oncologie and Recherche de mutations BRCA1 et BRCA2 | Individuals exploring hereditary health risks, Prospective parents wanting carrier status screening, Learning genetic predispositions to specific health conditions and Discovering ethnic lineage and geographic ancestry | Individuals with a family history of breast or ovarian cancer, Patients seeking proactive hereditary cancer risk assessment, Hereditary cancer risk screening and Preventive oncology planning |
| Action | Cerba lab | 23andMe | The Cancer Centre |
| Rate this product |
"BRCA1/BRCA2 A VISEE THERANOSTIQUE from Cerba lab."
Note: TopFind AI compiles product and service information for general comparison purposes only.